22 Nov 2019

Congratulations to Prof Mark Cooper on Diabetes grant!

Professor Mark Cooper giving CCS's
2017 public lecture. See video
Congratulations to Professor Mark Cooper, Head of Central Clinical School's Department of Diabetes, on his successful grant award from Diabetes Australia Research Program (DARP)! The grant of $60,000 is for one year, to investigate the mechanisms underlying the action of lowering glucose in type 2 diabetes (T2D) in a particular class of drugs known as Glucagon-like peptide-1 (GLP-1) receptor agonists.

These type of drugs improve cardiovascular (heart) and renal (kidney) outcomes, but it's not clear how or why given that there are no GLP-1 receptors in these organs. Prof Cooper is planning to test his hypothesis that specific hormone activity within cells is causing the protective effects.

No comments:

Post a Comment

Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.

Related Posts Plugin for WordPress, Blogger...